/PRNewswire/ Propel Bio Partners LP ("Propel" or "the Firm") today announced the commencement of its business operations, which will involve supporting life.
Scientists have discovered that a well-established cancer cell transcription factor and its newly identified co-factor work together to drive cancer cell proliferation, according to findings published in Science Advances.
11.03.2022 - Nexstim establishes a private equity company and is engaged into discussions with Dr. Joshua Kuluva on minority investment in the established company Company Announcement, Inside information, Helsinki, 11.03.2022 at 09:30 AM (EET) Nexstim Plc’s .
Nexstim establishes a private equity company and is engaged into discussions with Dr. Joshua Kuluva on minority investment in the established company .
Northwestern Medicine scientists have discovered a biomarker for one type of autism within patients' cerebrospinal fluid, according to a study published in the journal Neuron.